Reprogramming Immunity
Overcoming cancer immune resistance through microbiome derived technology
Reprogramming Immunity
Overcoming cancer immune resistance through microbiome derived technology
The Establishment of Ella Therapeutics
Ella Therapeutics was established as a spinoff from breakthrough research performed at the Ella Lemelbaum Institute for Immuno-oncology and Melanoma at Sheba Medical Center, ranked as one of the top ten hospitals in the world by Newsweek.
Our Mission and Unique Advantage
Our mission is to overcome cancer resistance to immune checkpoint inhibitors through alteration of the gut microbiome. We generate our proprietary data through human clinical testing accompanied by rigorous science and believe this differentiating strategy provides a unique advantage.
1
Alteration of Microbiome
2
Alteration of Immune Response
3
Clinical
Response
1
Alteration of Immune Response
2
Alteration of Immune Response
3
Clinical
Response